MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2018 International Congress

    Reversible Extrapyramidal features as unusual presentation of central pontine myelinolysis: A case report

    S. El-Jaafary, A. Sabbah, S. Ahmed (Cairo, Egypt)

    Objective: To be acquainted with the extrapyramidal symptoms developed during the course of central pontine myelinolysis. To emphasize the importance of neuroimaging in the diagnosis…
  • 2018 International Congress

    Clinical spectrum of vascular Parkinsonism: A hospital-based study in south India

    J. Kuragala, J. Murthy, N. Chaudhary, s. Sharma, S. Jaiswal, Y. Reddy (Anantapur, India)

    Objective: to Study the profile of akinetic rigid syndromes with special reference to Vascular Parkinsonism Background: Parkinson disease (PD) is a primary neurodegenerative disease but…
  • 2018 International Congress

    Serum fractalkine levels in Parkinson’s disease: Evidence for neuroinflammation

    G. Nagesh Babu, M. Gupta, V. Paliwal (Lucknow, India)

    Objective: Parkinson's disease (PD) is a debilitating neurodegenerative disorder characterized by loss of dopamine neurons in the substantia nigra. We measured neuroinflammatory marker fractalkine in…
  • 2018 International Congress

    Atypical Dopamine Responsive Parkinsonism in HIV Seroconversion

    N. Siddi Ganie, I. Siddi Ganie, N. Soni (Durban, South Africa)

    Objective: To add to the current body of knowledge of the association of HIV infection and dopamine responsive parkinsonism. Background: South Africa has one of…
  • 2018 International Congress

    Quantitative Midbrain Measurement in Diagnosing Variants of Progressive Supranuclear Palsy

    H. Wang, YW. Zhang, J. Yuan, D. Xu, H. You, ML. Li, F. Feng (Beijing, China)

    Objective: To evaluate the effectiveness of quantitative midbrain measurements in differentiating vPSP from multiple system atrophy (MSA) and Parkinson’s disease (PD). Background: Newly published criteria…
  • 2018 International Congress

    ARISE study: Study Design and Baseline Characteristics for a Phase 2 Trial of the Anti-Tau Antibody ABBV-8E12 in Progressive Supranuclear Palsy

    N. Mendonca, R. Bateman, A. Boxer, J. Braunstein, D. Claassen, D. Holtzman, D. Kerwin, B. Rendenbach-Mueller, H. Soares, D. Wang, G. Höglinger (Ludwigshafen, , Germany)

    Objective: This double-blind, placebo-controlled phase 2 study (M15-562 ARISE study, NCT02985879) assesses the safety and efficacy of ABBV-8E12 treatment in patients with progressive supranuclear palsy…
  • 2018 International Congress

    Striatal FP-CIT SPECT findings for progressive supranuclear palsy subtypes

    M. Yogo, M. Morita, M. Suzuki (Tokyo, Japan)

    Objective: In our previous study FP-CIT SPECT (FP-CIT) in progressive supranuclear palsy-Parkinsonism (PSP-P) revealed higher anterior striatal accumulation, and PSP- Richardson’s syndrome (PSP-RS) revealed lower…
  • 2018 International Congress

    A longitudinal study of brain quantitative MRI analysis before and after diagnosis of progressive supranuclear palsy

    K. Seo, T. Yamamoto, H. Kawasaki, A. Miyake, T. Hukuoka, Y. Nakazato, T. Takahasi, I. Matunari, H. Matuda, N. Tamura, N. Araki (Saitama, Japan)

    Objective: We analyzed longitudinal change in MRI imaging in PSP from the period before clinical diagnosis. Six patients with clinically diagnosed PSP including 1 case…
  • 2018 International Congress

    Cognitive impairment in multiple system atrophy: A Nepalese tertiary center study

    R. Ojha, K. Oli (Kathmandu, Nepal)

    Objective: This study was done to describe the clinical profile of MSA and evaluate the cognitive function using mini-mental state examination(MMSE). Background: Multiple system atrophy…
  • 2018 International Congress

    Probable MSA presenting initially with urinary retention

    S. Simeoni, R. Sakakibara, J. Panicker (London, United Kingdom)

    Objective: We describe 6 cases of probable MSA presenting with urinary retention/incomplete bladder emptying. Background: MSA is a progressive neurodegenerative adult-onset disease whose clinical features…
  • « Previous Page
  • 1
  • …
  • 1492
  • 1493
  • 1494
  • 1495
  • 1496
  • …
  • 1942
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley